Please press F5 on your keyboard to enter presentation mode Welcome to the Eastern Health Pathology guide to hsTnT. The information in this presentation.

Slides:



Advertisements
Similar presentations
Early assessment of myocardial injury by joint measurement of TnT-hs and Copeptin (1) J. Teixeira, (2) P. Wotquenne, (2) V. D’Orio, (3) D. Gruson, (1)
Advertisements

Tobias Reichlin, W. Hochholzer, C. Stelzig, K. Laule, M. Potocki, K
Student’s Research Group at the Department of Internal Medicine, Hypertension and Angiology The Medical University in Warsaw PULMONARY EMBOLISM – TOUGH.
Acute coronary syndrome : Risk stratification – markers of myocardial necrosis Paul Calle Emergency Department Ghent University Hospital Belgium.
Isoenzymes and Other Markers Mike Clark, M.D.. Isozymes (also known as isoenzymes) are enzymes that differ in amino acid sequence but catalyze the same.
Myocardial infarction New concepts New definitions.
High Sensitivity Troponin
British Cardiac Intervention Society Risk Assessment In Acute Coronary Syndromes Dr David Newby BHF Senior Lecturer in Cardiology Associate Director of.
L MACKAY, N CRINIS, Q LAM, R SCOTT
BASIC 12 LEAD ECG INTERPRETATION
OnSite Troponin I Rapid Test
DR. ABDULRAHMAN AL-AJLAN MYOCARDIAL INFARCTION. Introduction The heart is a muscular organ whose function is pumping of blood around the body. It consists.
Overly concerning and falsely reassuring?? FRAMINGHAM RISK FACTORS IN THE ED.
Journal Club Electronic Medical Record–Based Performance Improvement Project to Document and Reduce Excessive Cardiac Troponin Testing S.A. Love, Z.J.
ACUTE CORONARY SYNDORME EARLY RISK STRATIFICATION Sarah Jamison March 2003.
(clinical biochemistry of enzymes)
OnSite Troponin I Rapid Test. Cardiac markers are biomarkers measured to evaluate heart function.biomarkers They are often discussed in the context of.
1 Dr. Zahoor Ali Shaikh. 2 CORONARY ARTERY DISEASE (CAD)  CAD is most common form of heart disease and causes premature death.  In UK, 1 in 3 men and.
Acute Coronary Syndromes
Biochemical Markers of Myocardial Infarction
CRUSADE: A National Quality Improvement Initiative CRUSADE: A National Quality Improvement Initiative Can Rapid Risk Stratification of Unstable Angina.
ACUTE CORONARY SYNDROME (ACS). ACS Pathophysiology is that of a ruptured or eroded atheromatous plaque. Pathophysiology is that of a ruptured or eroded.
Ischemic Heart Disease CVS3 Hisham Alkhalidi. Ischemic Heart Disease A group of related syndromes resulting from myocardial ischemia.
Anything that you want to know about troponins but never ask
Biochemical Markers for Diagnosis of Myocardial Infarction Cardiovascular Block Medical Biochemistry Course Dr. Reem M. Sallam, MD, PhD.
ACUTE CORONARY SYNDROMES Part I. Definition Acute coronary syndrome (ACS) describes a spectrum of clinical conditions ranging from ST segment elevation.
Absolute and Relative Kinetic Changes of High-Sensitivity Cardiac Troponin T in Acute Coronary Syndrome and in Patients with Increased Troponin in the.
Biochemical Investigations In Heart Disaeses
Acute Coronary Syndromes. Learning outcomes To understand the clinical spectrum of coronary disease To recognise different presentations of the disease.
Enzymes, Cardiac Markers, Hepatic Tests clinically useful enzymes: tissue sources preanalytical variables affecting enzyme activities isoenzymes myocardial.
Ischaemic Heart Disease CASE A. CASE A: Mr HA, aged 60 years, was brought in to A&E complaining of chest pain, nausea and a suspected AMI.
Myocardial Infarction: Blood tests for diagnosis Dr Esmé Hitchcock CHEMICAL PATHOLOGIST.
Coronary Heart Disease (CHD) László Tornóci Inst. Pathophysiology Semmelweis University.
Implementation of a Sensitive Troponin I Assay and Risk of Recurrent Myocardial Infarction and Death in Patients With Suspected Acute Coronary Syndrome.
Biochemical Markers of Myocardial Infarction
Spectrum of Acute Coronary Syndromes: Laboratory Findings in Q-Wave AMI Creatine kinase evidence of necrosis NonePositive ECG early ST-segment depression.
Biochemical Markers for Diagnosis of Myocardial Infarction
Ischemic Heart Disease CVS3 Hisham Alkhalidi. Ischemic Heart Disease A group of related syndromes resulting from myocardial ischemia.
Cost Conscious Project: How Many Troponins Does It Take? Rola Khedraki.
RESEARCH POSTER PRESENTATION DESIGN © Cardiac Troponin Assay Cardiac troponin I is the diagnostic marker used for myocardial.
Troponin By Julie Moore C Dt204/2.
Chest Pain in the Emergency Department Junior Teaching C. Brown August 2015.
Date of download: 7/5/2016 Copyright © 2016 American Medical Association. All rights reserved. From: One-Hour Rule-out and Rule-in of Acute Myocardial.
Cost Containment: Use of Troponin testing in the Inpatient Wards Setting Neal Kaushal, R2 DSR2, May 2013.
Date of download: 9/17/2016 Copyright © The American College of Cardiology. All rights reserved. From: 2014 AHA/ACC Guideline for the Management of Patients.
Acute Coronary Syndrome
Biochemical Investigations In Heart Disaeses
Biochemical Markers of Myocardial Infarction
CARDIAC TROPONIN ASSAY-UTILITY IN DIAGNOSIS OF ACUTE CORONARY SYNDROME
Cardiac enzymes. 2 – Non enzyme proteins The Troponins
CORONARY ARTERY DISEASE
Tobias Reichlin, M. D. , Willibald Hochholzer, M. D
Cost Effective Use of Troponin to Rule Out Acute Coronary Syndrome
Coronary artery disease
Contemporary Diagnosis and Management of Unstable Angina
Cardiac enzymes and cardiac proteins
Section A: Introduction
European Heart Association Journal 2007 April
Nat. Rev. Cardiol. doi: /nrcardio
Advancing Acute Coronary Syndrome Assessment:
Cardiac enzymes. 2 – Non enzyme proteins The Troponins
Cardiac Troponin CHEST Volume 111, Issue 1, Pages 2-4 (January 1997)
Undetectable High Sensitivity Cardiac Troponin T Level in the Emergency Department and Risk of Myocardial Infarction Nadia Bandstein, MD; Rickard Ljung,
Undetectable High Sensitivity Cardiac Troponin T Level in the Emergency Department and Risk of Myocardial Infarction Nadia Bandstein, MD; Rickard Ljung,
High Sensitivity Troponin (hsTnT) : Result Interpretation Matrix*
Update on better disease diagnosis
Acute coronary syndromes: diagnosis
The Need for Serial Troponin Testing absolute cTn elevations are seen in multiple chronic cardiac and noncardiac conditions rise or fall !! in serial.
Pre-hospital prediction of transmural myocardial infarction and the need of acute coronary reperfusion by an artificial neural network compared to real-time.
Presentation transcript:

please press F5 on your keyboard to enter presentation mode Welcome to the Eastern Health Pathology guide to hsTnT. The information in this presentation has been collated by Dr Ann Read, Chemical Pathologist, and A/Prof Gish New, Director of Cardiology at Eastern Health, and prepared by Tony O’Neill from Pathology. Click here when you are ready to continue

High Sensitivity Troponin (hsTnT) What is it? Troponin (Tn) is a protein released from necrotic cardiac muscle cells. Two forms, TnI and TnT, can be found in the circulation when even minor necrosis occurs. Eastern Health Pathology has used a Roche TnT method since 1999 hsTnT is the latest generation of assay and will be used across EH from 7 th February 2011 onwards (replacing the existing TnT method) Assay Facts The new assay units are ng/L (previous methods were ng/mL) hsTnT results cannot be directly compared with the previous method Reference Range (as defined by 99 th percentile) is ng/L Almost all patients will have measurable TnT using this method, although most will be very low in the absence of ACS. Interpreting Results If Delta hsTnT is >50% and either result is >14 → supportive of ACS If hsTnT is elevated but stable (ie Delta hsTnT is <50%) → consider other causes of myocardial injury (see below). Non-STEMI (but not Unstable Angina) can be ruled out if both results are normal 6 hours after presentation and there are no other symptoms of ACS. A single normal result can be used if symptoms began more than 6 hours ago An elevated hsTnT is abnormal and suggestive of myocardial ischaemia, although not necessarily due to ACS. Note that UA is part of the spectrum of ACS, but does not require a rise in Troponin/CK or ECG changes When interpreting hsTnT results, the timeframe since symptom onset must be considered. Most ACS patients show a rapid rise in troponin levels 3-18 hours after the onset of chest pain, followed by a gradual decrease over a period of days Further information regarding clinical interpretation is provided overleaf Using Delta hsTnT Clinical Application Non-ACS causes of an elevated Troponin Agzew Y. Elevated serum cardiac troponin in non-acute coronary syndrome Clin Cardiol 2009; 32: A Result Interpretation Matrix has been provided on the next page to assist with interpretation of hsTnT results Patients who present with a clinical history suggestive of ACS and hsTnT of >100 ng/L can be provisionally diagnosed Diagnosis of non-ST Elevation Myocardial Infarction (non-STEMI) may require demonstration of a changing hsTnT level over paired samples collected at least 3 hours apart in the window 3-12 hours post symptom onset (Delta hsTnT). The Delta hsTnT can be calculated using the tool found in the online Pathology Handbook (the EH Intranet page) or at Click here when you are ready to proceed

hsTnT Result Interpretation Guide Click here when you are ready to proceed

ACS Classification Click here when you are ready to proceed

Clinical Progression of ACS Acute Coronary Syndrome Guidelines Working Group Med J Aust 2006 : 184 (8 Suppl); S9-29 Defining ACS Over Time Click here when you have finished

We hope this information has been useful for you. If you have any further questions, please do not hesitate to contact the Pathology Department at Box Hill Hospital If you have finished, please exit from Powerpoint and you will be returned to the intranet. If you wish to review this information further please click here and you will be returned to the beginning click here